Effects of Cognitive Training on Academic Task Performance in Attention Deficit Hyperactivity Disorder (ADHD) (Cog-RAST)
|ClinicalTrials.gov Identifier: NCT01124721|
Recruitment Status : Completed
First Posted : May 17, 2010
Last Update Posted : May 31, 2017
|Condition or disease||Intervention/treatment|
|ADHD Attention||Behavioral: Cognitive training Behavioral: Cognitive training-placebo|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||26 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Care Provider, Investigator)|
|Official Title:||Pilot Testing of Cognitive Training on Academic Task Performance in Children With Attention-deficit/Hyperactivity Disorder|
|Study Start Date :||January 2008|
|Primary Completion Date :||January 2013|
|Study Completion Date :||January 2013|
Experimental: Cogmed cognitive training
Computerized working memory, attention and cognitive tasks
Behavioral: Cognitive training
Cognitive computerized training for several days per week.
Other Name: Cogmed
Active Comparator: Active placebo
Cognitive training, however the training does not increase in difficulty, or does so to a minimal degree.
Behavioral: Cognitive training-placebo
Cognitive training that only minimally increases in difficulty
Other Name: Cogmed placebo
- Restricted Academic Situations Task [ Time Frame: 6 weeks ]Assessment of on-task type behavior while doing a simulated academic task.
- Working memory measures [ Time Frame: 6 weeks ]Assess memory and working memory functioning on computer and or RA administered tests.
- Rating scales [ Time Frame: 6 weeks ]Parent and teacher ratings of behavior and attention
- Fluency and attention measures [ Time Frame: 6 weeks ]Measures of fluency and attentional functioning.
- Self-control and executive functioning measures [ Time Frame: 6 weeks ]Attention and working memory components can affect delay discounting and self-control measures. This measure will assess for change in behavior and ratings associated with executive functioning.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01124721
|United States, California|
|UCaliforniaDavis MIND Institute|
|Sacramento, California, United States, 95825|
|Principal Investigator:||Julie Schweitzer, PhD||University of California, Davis|